In 2018, Shuoshan Xie et al. discovered that IFITM2, LY6E, DDX58, and IFI6 were expressed at higher levels in the muscle tissue of patients with DM, indicating the important role of the interferon (IFN) signaling pathway in the pathogenesis of DM [11]. This evidence concerns the gene LY6E and dermatomyositis.